Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

NSTK

Nastech Pharmaceutical Company (MM) (NSTK)

Nastech Pharmaceutical Company (MM)
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:NSTK
일자시간출처헤드라인심볼기업
2008/06/1003:31Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/06/0920:00Business WireNastech Announces Positive Intranasal Insulin Data at American Diabetes Association MeetingNASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/05/1507:55Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/05/1407:13Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/05/1306:28Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/05/0905:05Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Quarterly Report (10-Q)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/05/0905:03Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Current report filing (8-K)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/05/0905:00Business WireNastech Announces First Quarter 2008 Financial ResultsNASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/05/0205:00Business WireNastech to Release First Quarter Financial Results and Host Webcast on Thursday, May 8, 2008NASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/05/0106:19Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/05/0106:18Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Current report filing (8-K)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/04/3002:50Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Proxy Statement (definitive) (DEF 14A)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/04/2521:00Business WireNastech Pharmaceutical Company Inc. Raises $7.93 Million in Registered Direct OfferingNASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/04/1819:04Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/04/0305:53Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/04/0305:52Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/03/2721:00Business WireNastech Pharmaceutical Company Inc. Announces Appointment of Gunter Blobel, M.D., Ph.D., to its MDRNA, Inc. Scientific AdvisoryNASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/03/2601:41Business WireNastech Pharmaceutical Company Inc. to Present RNAi DataNASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/03/2205:00Business WireNastech Pharmaceutical Company Inc. Complies with Nasdaq Marketplace Rule 4350(b)(1)(B)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/03/2005:47Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/03/1910:36Business WireWall Street Media Presents a Video of Dr. Gordon Brandt, President of Nastech Pharmaceutical Company (NASDAQGM: NSTK)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/03/1805:09Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Annual Report (10-K)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/03/1805:03Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Current report filing (8-K)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/03/1805:00Business WireNastech Announces Fourth Quarter and Full Year 2007 Financial ResultsNASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/03/1321:00Business WireNastech Pharmaceutical Company Inc. to Present at the Invest Northwest CEO & Investor ForumNASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/03/1121:00Business WireNastech Pharmaceutical Company Inc. Completes Key RNAi Patent FilingsNASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/03/1105:17Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Current report filing (8-K)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/03/0722:00Business WireNastech Pharmaceutical Company Inc. Announces Scientific Advisory Board for MDRNA, Inc., its Wholly-Owned RNAi SubsidiaryNASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/03/0507:27Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Current report filing (8-K)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
2008/03/0104:23PR Newswire (US)Nastech Pharmaceutical Company Inc. to Hold Conference Call to Discuss Corporate Restructuring and Future Strategy on Monday, MaNASDAQ:NSTKNastech Pharmaceutical Company (MM)
 검색 관련기사 보기:NASDAQ:NSTK